Astragalus polysaccharides lowers plasma cholesterol through mechanisms distinct from statins

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Cheng, Yunjiu ^a   Tang, Kai ^a   Wu, Suhua ^a   Liu, Lijuan ^a   Qiang, Cancan ^a   Lin, Xiaoxiong ^a   Liu, Bingqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ASTRAGALUS POLYSACCHARIDE; BILE ACID; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; NEUTRAL STEROL; PLACEBO; SIMVASTATIN; STEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; POLYSACCHARIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INDUCTION; FECES ANALYSIS; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; LIPID ABSORPTION; LIPID BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SYRIAN HAMSTER; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ANIMAL; ASTRAGALUS PLANT; BIOSYNTHESIS; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; FECES; GENETICS; HAMSTER; HYPERLIPIDEMIA; INTESTINE ABSORPTION; LIVER; METABOLISM; PATHOLOGY; SMALL INTESTINE;

CRICETINAE;

ANIMALS; ASTRAGALUS PLANT; BILE ACIDS AND SALTS; CHOLESTEROL; CRICETINAE; FECES; GENE EXPRESSION REGULATION; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; INTESTINAL ABSORPTION; INTESTINE, SMALL; LIVER; MALE; POLYSACCHARIDES; RECEPTORS, LDL;

EID: 81155134398     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027437     Document Type: Article

References (39)

1. Collins R, Armitage J, Parish s, Sleight P, Peto R, et al. (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7-22.
2. Lenfant C, Cleeman JI, Ganiats TG, Graham G, Kleinman RE, et al. (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
3. Xu DJ, Xia Q, Wang JJ, Wang PP, (2008) Molecular weight and monosaccharide composition of Astragalus polysaccharides. Molecules 13: 2408-2415.
4. Huang X, Wang D, Hu Y, Lu Y, Guo Z, et al. (2008) Effect of sulfated astragalus polysaccharide on cellular infectivity of infectious bursal disease virus. Int J Biol Macromol 42: 166-171.
5. Dang SS, Jia XL, Song P, Cheng YA, Zhang X, et al. (2009) Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV. World J Gastroenterol 15: 5669-5673.
6. Zhao P, Su G, Xiao X, Hao E, Zhu X, et al. (2008) Chinese medicinal herb Radix Astragali suppresses cardiac contractile dysfunction and inflammation in a rat model of autoimmune myocarditis. Toxicol Lett 182: 29-35.
7. Li S, Zhang Y, Zhao J, (2007) Preparation and suppressive effect of astragalus polysaccharide in glomerulonephritis rats. Int Immunopharmacol 7: 23-28.
8. Li RJ, Qiu SD, Chen HX, Tian H, Wang HX, (2007) The immunotherapeutic effects of Astragalus polysaccharide in type 1 diabetic mice. Biol Pharm Bull 30: 470-476.
9. Wang J, Ito H, Shimura K, (1989) Enhancing effect of antitumor polysaccharide from Astragalus or Radix hedysarum on C3 cleavage production of macrophages in mice. Jpn J Pharmacol 51: 432-434.
10. Andersson H, (1992) The ileostomy model for the study of carbohydrate digestion and carbohydrate effects on sterol excretion in man. Eur J Clin Nutr 46 (Suppl 2): S69-S76.
11. Schneeman BO, (1999) Fiber, inulin and oligofructose: similarities and differences. J Nutr 129: 1424S-1427S.
12. Minekus M, Jelier M, Xiao JZ, Kondo S, Iwatsuki K, et al. (2005) Effect of partially hydrolyzed guar gum (PHGG) on the bioaccessibility of fat and cholesterol. Biosci Biotechnol Biochem 69: 932-938.
13. Fernandez ML, (2001) Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr Opin Lipidol 12: 35-40.
14. Ellegard L, Andersson H, (2007) Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study. Eur J Clin Nutr 61: 938-945.
15. Carr TP, Andresen CJ, Rudel LL, (1993) Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 26: 39-42.
16. Schwarz M, Russell DW, Dietschy JM, Turley SD, (1998) Marked reduction in bile acid synthesis in cholesterol 7alpha-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J Lipid Res 39: 1833-1843.
17. Temel RE, Gebre AK, Parks JS, Rudel LL, (2003) Compared with Acyl-CoA:cholesterol O-acyltransferase (ACAT) 1 and lecithin:cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol. J Biol Chem 278: 47594-47601.
18. Turley SD, Daggy BP, Dietschy JM, (1994) Psyllium augments the cholesterol-lowering action of cholestyramine in hamsters by enhancing sterol loss from the liver. Gastroenterology 107: 444-452.
19. Erickson SK, Cooper AD, Matsui SM, Gould RG, (1977) 7-Ketocholesterol. Its effects on hepatic cholesterogenesis and its hepatic metabolism in vivo and in vitro. J Biol Chem 252: 5186-5193.
20. van Heusden GP, Wirtz KW, (1984) Hydroxymethylglutaryl CoA reductase and the modulation of microsomal cholesterol content by the nonspecific lipid transfer protein. J Lipid Res 25: 27-32.
21. Levy E, Sinnett D, Thibault L, Nguyen TD, Delvin E, et al. (1996) Insulin modulation of newly synthesized apolipoproteins B-100 and B-48 in human fetal intestine: gene expression and mRNA editing are not involved. FEBS Lett 393: 253-258.
22. Vanstone CA, Raeini-Sarjaz M, Parsons WE, Jones PJ, (2002) Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons. Am J Clin Nutr 76: 1272-1278.
23. Wu CZ, Inoue M, Ogihara Y, (1998) Antihypercholesterolemic action of a traditional Chinese medicine (Kampo medicine), Ogi-Keishi-Gomotsu-To-Ka-Kojin. Biol Pharm Bull 21: 1311-1316.
24. Qureshi AA, Abuirmeileh N, Din ZZ, Ahmad Y, Burger WC, et al. (1983) Suppression of cholesterogenesis and reduction of LDL cholesterol by dietary ginseng and its fractions in chicken liver. Atherosclerosis 48: 81-94.
25. Yamamoto M, Kumagai A, Yamamura Y, (1983) Plasma lipid-lowering and lipogenesis-stimulating actions of ginseng saponins in tumor-bearing rats. Am J Chin Med 11: 88-95.
26. Ntanios FY, Jones PJ, (1999) Dietary sitostanol reciprocally influences cholesterol absorption and biosynthesis in hamsters and rabbits. Atherosclerosis 143: 341-351.
27. van Heek M, Farley C, Compton DS, Hoos L, Davis HR, (2001) Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. Br J Pharmacol 134: 409-417.
28. Altmann SW, Davis HJ, Zhu LJ, Yao X, Hoos LM, et al. (2004) Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303: 1201-1204.
29. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, et al. (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290: 1771-1775.
30. Russell DW, Setchell KD, (1992) Bile acid biosynthesis. Biochemistry 31: 4737-4749.
31. van Bennekum AM, Nguyen DV, Schulthess G, Hauser H, Phillips MC, (2005) Mechanisms of cholesterol-lowering effects of dietary insoluble fibres: relationships with intestinal and hepatic cholesterol parameters. Br J Nutr 94: 331-337.
32. Matthan NR, Pencina M, LaRocque JM, Jacques PF, D'Agostino RB, et al. (2009) Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD. J Lipid Res 50: 1927-1935.
33. Wang Y, Jones PJ, Woollett LA, Buckley DD, Yao L, et al. (2006) Effects of chenodeoxycholic acid and deoxycholic acid on cholesterol absorption and metabolism in humans. Transl Res 148: 37-45.
34. Brown MS, Goldstein JL, (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47.
35. Brown MS, Goldstein JL, (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340.
36. Reinoso RF, Sanchez NA, Garcia MJ, Prous JR, (2001) Pharmacokinetic interactions of statins. Methods Find Exp Clin Pharmacol 23: 541-566.
37. Wang YW, Jones PJ, Pischel I, Fairow C, (2003) Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters. Lipids 38: 165-170.
38. Ntanios FY, Jones PJ, (1998) Effects of variable dietary sitostanol concentrations on plasma lipid profile and phytosterol metabolism in hamsters. Biochim Biophys Acta 1390: 237-244.
39. Groot PH, Pearce NJ, Suckling KE, Eisenberg S, (1992) Effects of cholestyramine on lipoprotein levels and metabolism in Syrian hamsters. Biochim Biophys Acta 1123: 76-84.